Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VS-105 by Vidasym for Osteoporosis: Likelihood of Approval
VS-105 is under clinical development by Vidasym and currently in Phase I for Osteoporosis. According to GlobalData, Phase I drugs...